These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 15752379

  • 1. Population pharmacokinetics of orally administered paclitaxel formulated in Cremophor EL.
    de Jonge ME, Huitema AD, Schellens JH, Rodenhuis S, Beijnen JH.
    Br J Clin Pharmacol; 2005 Mar; 59(3):325-34. PubMed ID: 15752379
    [Abstract] [Full Text] [Related]

  • 2. Influence of Cremophor El on the bioavailability of intraperitoneal paclitaxel.
    Gelderblom H, Verweij J, van Zomeren DM, Buijs D, Ouwens L, Nooter K, Stoter G, Sparreboom A.
    Clin Cancer Res; 2002 Apr; 8(4):1237-41. PubMed ID: 11948138
    [Abstract] [Full Text] [Related]

  • 3. Disposition kinetics of taxanes after intraperitoneal administration in rats and influence of surfactant vehicles.
    Yokogawa K, Jin M, Furui N, Yamazaki M, Yoshihara H, Nomura M, Furukawa H, Ishizaki J, Fushida S, Miwa K, Miyamoto K.
    J Pharm Pharmacol; 2004 May; 56(5):629-34. PubMed ID: 15142340
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cremophor EL-mediated alteration of paclitaxel distribution in human blood: clinical pharmacokinetic implications.
    Sparreboom A, van Zuylen L, Brouwer E, Loos WJ, de Bruijn P, Gelderblom H, Pillay M, Nooter K, Stoter G, Verweij J.
    Cancer Res; 1999 Apr 01; 59(7):1454-7. PubMed ID: 10197613
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The co-solvent Cremophor EL limits absorption of orally administered paclitaxel in cancer patients.
    Malingré MM, Schellens JH, Van Tellingen O, Ouwehand M, Bardelmeijer HA, Rosing H, Koopman FJ, Schot ME, Ten Bokkel Huinink WW, Beijnen JH.
    Br J Cancer; 2001 Nov 16; 85(10):1472-7. PubMed ID: 11720431
    [Abstract] [Full Text] [Related]

  • 10. Comparative pharmacokinetics of unbound paclitaxel during 1- and 3-hour infusions.
    Gelderblom H, Mross K, ten Tije AJ, Behringer D, Mielke S, van Zomeren DM, Verweij J, Sparreboom A.
    J Clin Oncol; 2002 Jan 15; 20(2):574-81. PubMed ID: 11786588
    [Abstract] [Full Text] [Related]

  • 11. Disposition of Cremophor EL in humans limits the potential for modulation of the multidrug resistance phenotype in vivo.
    Sparreboom A, Verweij J, van der Burg ME, Loos WJ, Brouwer E, Viganò L, Locatelli A, de Vos AI, Nooter K, Stoter G, Gianni L.
    Clin Cancer Res; 1998 Aug 15; 4(8):1937-42. PubMed ID: 9717822
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Measurement of fraction unbound paclitaxel in human plasma.
    Brouwer E, Verweij J, De Bruijn P, Loos WJ, Pillay M, Buijs D, Sparreboom A.
    Drug Metab Dispos; 2000 Oct 15; 28(10):1141-5. PubMed ID: 10997930
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Modulation of cisplatin pharmacodynamics by Cremophor EL: experimental and clinical studies.
    Gelderblom H, Loos WJ, Verweij J, van der Burg ME, de Jonge MJ, Brouwer E, Nooter K, Stoter G, Sparreboom A.
    Eur J Cancer; 2002 Jan 15; 38(1):205-13. PubMed ID: 11750851
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of paclitaxel elimination in the isolated perfused rat liver by Cremophor EL.
    Ellis AG, Webster LK.
    Cancer Chemother Pharmacol; 1999 Jan 15; 43(1):13-8. PubMed ID: 9923536
    [Abstract] [Full Text] [Related]

  • 20. Entrapment by Cremophor EL decreases the absorption of paclitaxel from the gut.
    Bardelmeijer HA, Ouwehand M, Malingré MM, Schellens J, Beijnen JH, van Tellingen O.
    Cancer Chemother Pharmacol; 2002 Feb 15; 49(2):119-25. PubMed ID: 11862425
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.